PPMD’s GIFTED Initiative: Drug Development Corporate Grant
05/12/2017 13:47
Objetivo: The corporate funding program is part of PPMD’s GIFTED initiative (Global Investment For Therapeutics to End Duchenne) and is focused on the development of new drugs for Duchenne and Becker muscular dystrophy (the “dystrophinopathies”). The ideal project will yield data that will help a company raise funds from other investors to move the candidate forward to the next stage of clinical development.
Inscrições: durante todo o ano
Mais informações no site.
